Phase I/II trial of erlotinib, radiation therapy, and cisplatin in patients with complete resected squamous cell carcinoma of the head and neck.

Trial Profile

Phase I/II trial of erlotinib, radiation therapy, and cisplatin in patients with complete resected squamous cell carcinoma of the head and neck.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 01 Oct 2016

At a glance

  • Drugs Cisplatin (Primary) ; Erlotinib (Primary)
  • Indications Head and neck cancer
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 23 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 08 Jun 2010 Thirty-two patients have been enrolled since the beginning of phase II, according to information reported at ASCO 2010.
    • 11 Apr 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top